Can You Capture & Value The Price Of Speed?: Outsourcing For Drug Development & Manufacturing
- Topics:
- Pricing Strategy
- Source:
- The Foundation Group
FREE Registration is required
Overview: Outsourcing drug research has become more popular, not only because of increased efficiencies in third-party core competencies, but also because numerous Pharmaceutical & Biotech companies are often challenged with conflicting budgets, dated equipment, software or knowledge that may or may not fall short of existing regulatory allowances. Emphasis has traditionally been placed on chemical methodologies over technological advances and process design, therefore, even if a faster process is discovered many companies do not have the capacity or budget to execute it. In the Pharmaceutical and Biotech industry, the fastest possible turnaround time for a new drug launch is critical for success. Within this industry, companies clearly consider the attribute of "speed" to be of great importance, and value it accordingly based on the segmentation pattern to which they would reside. Speed to market translates into superior performance allowing Pharmaceutical and Biotech companies to gain a leg-up on competing generic counterparts by stretching short-term exposure to revenue erosion.
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: HTML | Date: Jan 2003 | Pages: 1
